From: sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
Variable | Control group | Study group | p |
---|---|---|---|
Number, of patients n(%) | 57 (45,6) | 68 (54,4) | |
Age, years, median (IQR) | 37(30,5;40) | 33(29;36) | 0,014* |
COVID-19 severity, n (%) | 68 (100) | ||
1- mild illness | 59 (86,76) | ||
2- moderate illness | 8 (11,76) | ||
3- severe illness | 1 (1,47) | ||
4- critical illness | 0 (0) | ||
Body mass index(kg/m2) median (IQR) | 28,57 (25,69;31,005) | 29,660 (26,447;33,453) | 0,29* |
First pregnancy n(%) | 32 (56,1) | 33 (48,5) | 0.504** |
IVF, n (%) | 10 (17,5) | 6 (8,8) | 0.236** |
Smoking, n (%) | 0 (0) | 2 (2,9) | 0,5*** |
PGDM, n (%) | 1 (1,75) | 2 (2,9) | 1,0*** |
Chronic hipertension, n (%) | 2 (3,5) | 3 (4,4) | 1,0*** |
Chronic renal disease, n (%) | 1 (1,75) | 0 (0) | 0.456*** |